Preparation of a 35S Labelled Trimeprazine Tartrate Sustained Action Product for its Evaluation in Man
- 1 December 1960
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 12 (Supplement) , 237T-244T
- https://doi.org/10.1111/j.2042-7158.1960.tb10481.x
Abstract
Multi-pellet sustained action capsules containing radiochemically labelled drug were prepared by a pan coating procedure. Pellets of varying lipid thickness were prepared, and mixed in different proportions to obtain products having variable in vitro release characteristics. Capsules were prepared from these pellets for administration to man. Oral doses of 5 mg. of labelled trimeprazine were given in a non-sustained release form at 0, 4, and 8 hours. Other subjects received single 15 mg. oral doses of labelled trimeprazine in sustained action capsules. The 35S activity was determined in blood and urine at selected times. Sustained action capsules were prepared which when evaluated in man gave data for 35S activity in blood and urine which were comparable to that observed for three divided doses of non-sustained release drug administered at 0, 4, and 8 hours.Keywords
This publication has 4 references indexed in Scilit:
- Sulfaethylthiadiazole V**Research and Development Division of Smith Kline and French Laboratories, Philadelphia 1, PaJournal of the American Pharmaceutical Association (Scientific ed.), 1959
- The effect of dosage forms on the duration and continuity of action of belladonna alkaloidsDigestive Diseases and Sciences, 1959
- Liquid Scintillation Counting of C14 and H3 in Plasma and SerumExperimental Biology and Medicine, 1958
- Sulfaethylthiadiazole III. **Smith, Kline & French Laboratories, Philadelphia 1, Pa.Journal of the American Pharmaceutical Association (Scientific ed.), 1958